Page last updated: 2024-09-05
tesaglitazar and sumatriptan
tesaglitazar has been researched along with sumatriptan in 3 studies
Compound Research Comparison
Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (sumatriptan) | Trials (sumatriptan) | Recent Studies (post-2010) (sumatriptan) |
---|---|---|---|---|---|
74 | 13 | 25 | 2,405 | 461 | 480 |
Protein Interaction Comparison
Protein | Taxonomy | tesaglitazar (IC50) | sumatriptan (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0073 | |
5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0073 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.4497 | |
Carboxypeptidase M | Homo sapiens (human) | 0.02 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.64 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.722 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.64 | |
5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.3091 | |
5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 0.0131 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 7.9433 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 3.9753 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.804 | |
5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 0.061 | |
5-hydroxytryptamine receptor 1E | Homo sapiens (human) | 5.5 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.64 | |
5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0078 | |
5-hydroxytryptamine receptor 5A | Homo sapiens (human) | 0.5012 | |
5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 0.02 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.45 | |
5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0073 | |
5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0073 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 6.7 |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Other Studies
3 other study(ies) available for tesaglitazar and sumatriptan
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |